Apellis Pharmaceuticals ^Investors

Apellis Pharmaceuticals is a venture capital fund based in Waltham, Massachusetts, established in 2008 The firm specializes in investing in innovative biopharmaceutical companies that are focused on developing novel therapies With a significant investment scale of $149,966,000, Apellis is committed to advancing the treatment of serious diseases The fund aims to foster growth and innovation within the healthcare sector by supporting promising ventures Apellis Pharmaceuticals is recognized for its strategic approach to investment and its dedication to improving patient outcomes